A New Device Improves Signs and Symptoms of TMD.

Background: Temporomandibular joint dysfunction (TMD) therapy remains an open challenge for modern dentistry. Herein, we propose a new neuromuscular lingual device able to reduce signs and symptoms of TMD in female patients with chronic orofacial pain.

Methods: 50 females with myofascial TMD according to RDC/TMD were randomly assigned to study ( n  = 25) and control groups ( n  = 25). At T0, both groups received sEMG/KNG and pain evaluation by the VAS scale. The study group received the ELIBA device (lingual elevator by Balercia) constructed under ULF-TENS (ultra-low-frequency transcoutaneous electrical nervous stimulation). Subjects were instructed to use ELIBA at least for 16 h/day. After 6 months (T1), both groups underwent to sEMG/KNG and VAS revaluation.

Results: T1 study group compared to controls showed a significant reduction in total ( p < 0.0001) and mean ( p < 0.0001) sEMG values, as well as a significant increase in both maximum vertical mouth opening ( p =0.003) and maximum velocity in mouth opening ( p =0.003) and closing ( p < 0.0001). Interestingly, a significant reduction in pain measured by VAS ( p < 0.0001) was reported.

Conclusions: After 6 months, the ELIBA device is able to significantly reduce TMD-associated myogenous pain and to promote the enhancement of sEMG/KNG values.

Practical Implications: ELIBA can be considered as a new device, potentially useful for head-neck pain relief in patients suffering from chronic TMD. In addition, its use promotes a muscles relaxation inducing freeway space increase. This characteristic makes it particularly useful for rehabilitation of patients with not enough space for construction of conventional orthotics or neuromuscular bites.